 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Michigan Team Develops Strategy to ID Cancer Drug Targets from RNA-seq Data
February 20, 2013
Michigan Team Develops Strategy to ID Cancer Drug Targets from RNA-seq Data
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- At AACR, Early Providers of NGS-based Cancer Panels Debate 'Actionable' Mutations, Regulatory Issues
April 10, 2013 / Clinical Sequencing News - After a Year of Lessons Learned, Michigan Looks to Expand Comprehensive Clinical Cancer Sequencing
December 19, 2012 / Clinical Sequencing News - Foundation Medicine Preps for June Launch of Cancer Dx; Looks to Expand to RNA-Seq
February 22, 2012 / Clinical Sequencing News - Cancer Sequencing Takes off in 2011 Amid Debate on Benefits of Targeted vs. Comprehensive Approaches
January 11, 2012 / Clinical Sequencing News - Adaptive Bio, Bristol-Myers Squibb Collaborate on Cancer Biomarkers
May 9, 2013 / GenomeWeb Daily News